PUBLICATIONS - Report on the European Market for Neurodiagnostic Products:
This article was originally published in Clinica
International marketing consultancy Frost & Sullivan has published a report on The European Market for Neurodiagnostic Products. It looks at the different sectors within the market and discusses future growth. The report also gives a detailed account of the trends emerging from the market, as manufacturers attempt to find ways of increasing their end-user base and to meet the demands for clinical and cost-effective care in Europe's healthcare market. For more information contact Frost & Sullivan's UK office. Tel: +44 171 915 7824. Fax: +44 171 730 3343.
You may also be interested in...
Executives On The Move: BMS Taps Barclays Exec For Strategy Spot, Epizyme Selects Science Chief And A Board Election At ADC Therapeutics
Bristol-Myers Squibb taps Barclays chair of global life sciences as it EVP, strategy and business development, and cancer therapeutics firm Epizyme Inc. selects a chief scientific officer. At ADC Therapeutics, an oncology drug development company, a new chairman is elected.
Non-CE-marked products on the EU market, virtual notified body audits, free standards and the Commission bid to pause the MDR. March has seen unprecedented developments as COVID-19 has railroaded through the sector decimating regulatory rules and plans.
Jubilant Life Sciences anticipates continued strong demand despite temporary logistics blips in India and expects to resume operations at its Nanjangud plant, currently shut down due to a few COVID-19 cases among employees, by mid-April. It is also evaluating the feasibility of manufacturing some of the APIs recently incentivized by the Indian government.